Literature DB >> 33687660

Anti-Vpr activities of sesqui- and diterpenoids from the roots and rhizomes of Kaempferia candida.

Takeshi Kodama1, Hnin Htet Wai Nyunt2, Hla Ngwe2, Ikuro Abe3,4, Hiroyuki Morita5.   

Abstract

New copaene-type and nerolidol-type sesquiterpenoids, 7-hydroxymustakone (1) and 15-hydroxynerolidol (2), and a 15-norlabdane diterpenoid, kaempcandiol (3), together with four known compounds (4-7) were isolated from the chloroform extract of Kaempferia candida roots and rhizomes. The structures of the new compounds 1-3 were elucidated based on 1D and 2D NMR and HRESIMS spectroscopic analyses. The extract of the K. candida roots and rhizomes and all isolated compounds 1-7 possessed HIV-1 viral protein R (Vpr) inhibitory activities on the TREx-HeLa-Vpr cell line at a 5 μM concentration, without detectable cytotoxicity.

Entities:  

Keywords:  Diterpenoids; Kaempferia candida; Sesquiterpenoids; Vpr

Year:  2021        PMID: 33687660     DOI: 10.1007/s11418-020-01480-z

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  35 in total

1.  Genetic variation of Kaempferia (Zingiberaceae) in Thailand based on chloroplast DNA (psbA-trnH and petA-psbJ) sequences.

Authors:  J Techaprasan; S Klinbunga; C Ngamriabsakul; T Jenjittikul
Journal:  Genet Mol Res       Date:  2010-10-05

2.  Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.

Authors:  Nobumoto Watanabe; Yoshifumi Nishihara; Tomoyuki Yamaguchi; Atsushi Koito; Hiroyuki Miyoshi; Hideaki Kakeya; Hiroyuki Osada
Journal:  FEBS Lett       Date:  2006-04-19       Impact factor: 4.124

3.  Identification of a novel Vpr-binding compound that inhibits HIV-1 multiplication in macrophages by chemical array.

Authors:  Kyoji Hagiwara; Tomoyuki Murakami; Guangai Xue; Yasuo Shimizu; Eri Takeda; Yoshie Hashimoto; Kaori Honda; Yasumitsu Kondoh; Hiroyuki Osada; Yasuko Tsunetsugu-Yokota; Yoko Aida
Journal:  Biochem Biophys Res Commun       Date:  2010-10-29       Impact factor: 3.575

4.  Isopimarane diterpenoids from Kaempferia pulchra rhizomes collected in Myanmar and their Vpr inhibitory activity.

Authors:  Nwet Nwet Win; Takuya Ito; Takashi Matsui; Simayijiang Aimaiti; Takeshi Kodama; Hla Ngwe; Yasuko Okamoto; Masami Tanaka; Yoshinori Asakawa; Ikuro Abe; Hiroyuki Morita
Journal:  Bioorg Med Chem Lett       Date:  2016-02-15       Impact factor: 2.823

5.  Roscotanes and roscoranes: Oxygenated abietane and pimarane diterpenoids from Kaempferia roscoeana.

Authors:  Jutatip Boonsombat; Chulabhorn Mahidol; Pornsuda Chawengrum; Nanthawan Reuk-Ngam; Nitirat Chimnoi; Supanna Techasakul; Somsak Ruchirawat; Sanit Thongnest
Journal:  Phytochemistry       Date:  2017-07-28       Impact factor: 4.072

6.  Efficacy of Kaempferia parviflora in a mouse model of obesity-induced dermatopathy.

Authors:  Moeko Hidaka; Kazumasa Horikawa; Tomoko Akase; Hiroko Makihara; Takatoshi Ogami; Hiroshi Tomozawa; Masahito Tsubata; Ai Ibuki; Yutaka Matsumoto
Journal:  J Nat Med       Date:  2016-09-03       Impact factor: 2.343

7.  Kaemgalangol A: Unusual seco-isopimarane diterpenoid from aromatic ginger Kaempferia galanga.

Authors:  Ningombam Swapana; Takehiro Tominaga; Abdelsamed I Elshamy; Mahmoud A A Ibrahim; Mohamed-Elamir F Hegazy; Ch Brajakishor Singh; Midori Suenaga; Hiroshi Imagawa; Masaaki Noji; Akemi Umeyama
Journal:  Fitoterapia       Date:  2018-06-18       Impact factor: 2.882

8.  Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora.

Authors:  Pattara Sawasdee; Chalisa Sabphon; Duangporn Sitthiwongwanit; Udom Kokpol
Journal:  Phytother Res       Date:  2009-12       Impact factor: 5.878

9.  Evolution of the primate lentiviruses: evidence from vpx and vpr.

Authors:  M Tristem; C Marshall; A Karpas; F Hill
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

Review 10.  The Vpr protein from HIV-1: distinct roles along the viral life cycle.

Authors:  Erwann Le Rouzic; Serge Benichou
Journal:  Retrovirology       Date:  2005-02-22       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.